These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 8973428)

  • 1. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP).
    Merkel C; Marin R; Enzo E; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Sacerdoti D; Felder M; Mazzaro C; Beltrame P; Gatta A
    Lancet; 1996 Dec 21-28; 348(9043):1677-81. PubMed ID: 8973428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.
    Villanueva C; Miñana J; Ortiz J; Gallego A; Soriano G; Torras X; Sáinz S; Boadas J; Cussó X; Guarner C; Balanzó J
    N Engl J Med; 2001 Aug; 345(9):647-55. PubMed ID: 11547718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
    Merkel C; Marin R; Sacerdoti D; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Bolognesi M; Felder M; Mazzaro C; Gatta A
    Hepatology; 2000 Feb; 31(2):324-9. PubMed ID: 10655253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding.
    Villanueva C; Balanzó J; Novella MT; Soriano G; Sáinz S; Torras X; Cussó X; Guarner C; Vilardell F
    N Engl J Med; 1996 Jun; 334(25):1624-9. PubMed ID: 8628357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial.
    García-Pagán JC; Villanueva C; Albillos A; Bañares R; Morillas R; Abraldes JG; Bosch J;
    Gut; 2009 Aug; 58(8):1144-50. PubMed ID: 19218249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effect of nadolol or nadolol plus isosorbide-5-mononitrate on renal function and ascites formation in patients with cirrhosis. GTIP Gruppo Triveneto per l'Ipertensione Portale.
    Merkel C; Gatta A; Donada C; Enzo E; Marin R; Amodio P; Torboli P; Angeli P; Cavallarin G; Sebastianelli G
    Hepatology; 1995 Sep; 22(3):808-13. PubMed ID: 7657286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should nitrates be used with beta blockers to prevent variceal bleeding?
    Zalepuga R; Herrera JL
    Am J Gastroenterol; 2000 Oct; 95(10):2982-3. PubMed ID: 11051383
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of endoscopic variceal ligation and nadolol plus isosorbide-5-mononitrate in the prevention of first variceal bleeding in cirrhotic patients.
    Wang HM; Lo GH; Chen WC; Tsai WL; Chan HH; Cheng LC; Hsu PI; Lai KH
    J Chin Med Assoc; 2006 Oct; 69(10):453-60. PubMed ID: 17098669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding.
    Lo GH; Chen WC; Wang HM; Yu HC
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1681-7. PubMed ID: 22849337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding.
    Lo GH; Chen WC; Chen MH; Hsu PI; Lin CK; Tsai WL; Lai KH
    Gastroenterology; 2002 Sep; 123(3):728-34. PubMed ID: 12198699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites.
    Borroni G; Salerno F; Cazzaniga M; Bissoli F; Lorenzano E; Maggi A; Visentin S; Panzeri A; de Franchis R
    J Hepatol; 2002 Sep; 37(3):315-21. PubMed ID: 12175626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
    Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Bellini B; Bighin R; Gatta A
    Hepatology; 2000 Nov; 32(5):930-4. PubMed ID: 11050041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients.
    Sarin SK; Wadhawan M; Gupta R; Shahi H
    Dig Dis Sci; 2005 Aug; 50(8):1538-47. PubMed ID: 16110851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT.
    García-Pagán JC; Morillas R; Bañares R; Albillos A; Villanueva C; Vila C; Genescà J; Jimenez M; Rodriguez M; Calleja JL; Balanzó J; García-Durán F; Planas R; Bosch J;
    Hepatology; 2003 Jun; 37(6):1260-6. PubMed ID: 12774003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of propranolol or propranolol plus isosorbide-5-mononitrate on variceal pressure in schistosomiasis.
    Kong DR; Ma C; Wang M; Wang JG; Chen C; Zhang L; Hao JH; Li P; Xu JM
    World J Gastroenterol; 2013 Jul; 19(26):4228-33. PubMed ID: 23864788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined therapy for secondary prophylaxis of variceal rebleeding?
    Maldonado D; Barkin JS
    Am J Gastroenterol; 2002 Aug; 97(8):2134-6. PubMed ID: 12190191
    [No Abstract]   [Full Text] [Related]  

  • 17. Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients.
    Bolognesi M; Sacerdoti D; Merkel C; Gatta A
    J Ultrasound Med; 1994 Dec; 13(12):945-52. PubMed ID: 7877205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'high-risk' varices.
    Sharma P; Kumar A; Sharma BC; Sarin SK
    Aliment Pharmacol Ther; 2009 Jul; 30(1):48-60. PubMed ID: 19392862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy.
    Villanueva C; Aracil C; Colomo A; Lopez-Balaguer JM; Piqueras M; Gonzalez B; Torras X; Guarner C; Balanzo J
    Aliment Pharmacol Ther; 2009 Feb; 29(4):397-408. PubMed ID: 19006538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin plus isosorbide 5-mononitrate versus somatostatin in the control of acute gastro-oesophageal variceal bleeding: a double blind, randomised, placebo controlled clinical trial.
    Junquera F; López-Talavera JC; Mearin F; Saperas E; Videla S; Armengol JR; Esteban R; Malagelada JR
    Gut; 2000 Jan; 46(1):127-32. PubMed ID: 10601068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.